bioRxiv Science⌕ Search

Biology subjects

Ruppert, M.

Publications and source records attributed to Ruppert, M..

3 recordsLinked to original sources

The Drosophila tyramine-beta-hydroxylase gene encodes multiple isoforms with different functions

The Tyramine-beta-hydroxylase (Tbh) is required for octopamine synthesis. To better understand the function of Tbh in neurotransmitter synthesis, we analyzed the molecular genetic organization of the Drosophila melanogaster Tbh gene and found that the Tbh gene encodes multiple transcripts. The transcripts differ in their 5UTR, which results in proteins that differ in their size and putative phosphorylation sites, suggesting that the Tbh function is regulated at translational and posttranslational levels. We generated a new Tbh mutant - TbhDel3 - using FLP/FRT recombination mutagenesis to remove the translational start site still that is present in TbhnM18mutants. The TbhDel3 mutants share ethanol tolerance and larval locomotion defects with the TbhnM18 mutants. But, they differ in terms of their cellular stress response. To develop normal levels of ethanol tolerance, Tbh is required in a subset of Tbh expressing neurons in the adult brain, which was identified using a newly generated Tbh-Gal4 driver. Taking advantage of a newly generated Tbh antibody serum, we show that one Tbh isoform is expressed in a group of peptidergic Hugin-positive and noradrenergic neurons uncoupling Tbh function from octopamine synthesis. The existence of different functional Tbh isoforms impacts our understanding of the regulatory mechanisms of neurotransmitter synthesis and the function of the octopaminergic neurotransmitter system in cellular processes and the regulation of behavior. Author SummaryVertebrates and insects have structurally identical signaling molecules in their nervous system, such as the neurotransmitter dopamine. But, there are also neurotransmitters that are thought to only occur in the vertebrate or insect brain. Noradrenaline is one such neurotransmitter that regulates flight and fight responses in vertebrates. In insects such as the fruit fly Drosophila melanogaster, the structurally very similar neurotransmitter octopamine is considered to be an invertebrate-specific neurotransmitter that performs similar functions to noradrenaline. The functional similarities also extend to enzymes required for synthesis. Our analysis shows that the enzyme for octopamine synthesis exists in several variations and that the connection between the enzymes and the synthesized neurotransmitter may not be as simple as presumed. Exploiting molecular, behavioral and neuroanatomical studies, we show that different variants might be used in response to different environmental conditions and/or the synthesis of alternative, structurally similar neurotransmitters, such as noradrenaline. These results challenge our view on the functions of octopamine and noradrenaline in the regulation of behavior.

neuroscience↗

The potential of Senicapoc, a KCNN4 inhibitor, for the prevention and treatment of breast cancer

BackgroundGenome-wide association studies have identified a breast cancer risk locus at 19q13.31. The candidate causal variants at this locus are located in the first exon of KCNN4. KCNN4, which regulates membrane potential and Ca2+ signaling, is a good candidate for drug repositioning because its inhibitor, Senicapoc, has been shown to be well tolerated in Phase-II and -III clinical trials for asthma and sickle cell anemia. MethodsWe evaluated public mRNA expression data to determine whether the allele at 19q13.31 associated with increased breast cancer risk was associated with KCNN4 expression. We also used immunohistochemistry to evaluate the relationship between KCNN4 protein expression and breast cancer survival. We then used Senicapoc in two murine mammary tumor models to determine if it would delay tumor development. We also treated mice bearing 4T1 mammary tumors with Senicapoc, by subcutaneous injection and by oral gavage. Finally we used gene editing to make deletions within Kcnn4 in 4T1 to determine whether Senicapoc had off-target effects on tumor growth. ResultsAnalysis of the Genotype-Tissue Expression Project showed that the allele at 19q13.31 associated with increased breast cancer risk is associated with increased KCNN4 expression, suggesting that inhibiting KCNN4 might reduce breast cancer risk. Using immunohistochemistry in a large breast cancer cohort, we found that membrane and cytoplasmic expression is a marker of poor prognosis in triple negative breast cancer. We then tested the efficacy of Senicapoc to prevent and treat breast cancer. This showed that it delays the development of mammary tumors in two murine models, and slows growth of a syngeneic (4T1) model of triple negative breast cancer. Senicapoc monotherapy showed similar efficacy to anthracycline/taxane-based chemotherapy in these studies, with a stronger effect when they were combined. ConclusionsThese results provide a rationale for clinical testing of Senicapoc for treating, and even preventing, breast cancer.

cancer biology↗

Mutation of the Drosophila serotonin transporter dSERT disrupts courtship and feeding and increases both daytime and nighttime sleep

The Serotonin Transporter (SERT) regulates extracellular serotonin levels and is the target of most current drugs used to treat depression. The mechanisms by which inhibition of SERT activity influences behavior are poorly understood. To address this question in the model organism Drosophila melanogaster, we developed new loss of function mutations in Drosophila SERT (dSERT). Previous studies in both flies and mammals have implicated serotonin as an important neuromodulator of sleep, and our newly generated dSERT mutants show an increase in total sleep and altered sleep architecture. Differences in daytime vs. nighttime sleep architecture as well as genetic rescue experiments unexpectedly suggest that distinct serotonergic circuits may modulate daytime versus nighttime sleep. dSERT mutants also show defects in copulation and food intake, akin to the clinical side effects of SSRIs. Starvation did not overcome the sleep drive in the mutants. Additionally in males, but not female dSERT mutants, the drive to mate also failed to overcome sleep drive. dSERT may be used to further explore the mechanisms by which serotonin regulates sleep and its interplay with other complex behaviors. Author SummaryMany medications used to treat depression and anxiety act by changing serotonin levels in the brain. Fruit flies also use serotonin and can be used as a model to study the brain. We have made a fly mutant for the serotonin transporter (SERT), which is the target of antidepressants in humans. The mutants sleep more, eat less, and have a decreased sex drive. These flies can be used to study the neuronal pathways by which serotonin regulates sleep, eating and sexual behaviors and may help us to understand the behavioral effects of antidepressants.

neuroscience↗